Comparison of prophylactic effect of topical Alchemilla vulgaris in glycerine versus that of dexamethasone on postoperative sore throat after tracheal intubation using a double-lumen endobronchial tube: a randomized controlled study.
Alchemilla vulgaris
Dexamethasone
Glycerine
Hoarseness
Sore throat
Journal
Anesthesia and pain medicine
ISSN: 2383-7977
Titre abrégé: Anesth Pain Med (Seoul)
Pays: Korea (South)
ID NLM: 101517708
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
05
10
2020
accepted:
19
11
2020
pubmed:
20
4
2021
medline:
20
4
2021
entrez:
19
4
2021
Statut:
ppublish
Résumé
Sore throat and hoarseness frequently occur following general anesthesia with tracheal intubation and are effectively reduced when dexamethasone is used prophylactically. Alchemilla vulgaris in glycerine (Neo Mucosal Activator®) suppresses inflammatory response, possibly relieving sore throat. We enrolled 94 patients (age ≥ 18 years) scheduled for thoracic surgery using double-lumen tube intubation. Before intubation, 0.2 mg/kg of dexamethasone was administered intravenously and 2 ml of normal saline was sprayed into the oropharyngeal cavity (Group D; n = 45), or 0.04 ml/kg normal saline was administered intravenously and 1 g of Neo Mucosal Activator® mixed with 1 ml of normal saline was sprayed into the oropharyngeal cavity (Group N; n = 43), in a double blind and prospectively randomized manner. Postoperative sore throat and hoarseness were recorded using a numeral rating scale and a 4-point scale to detect a change in voice quality following tracheal extubation (at 1, 6, and 24 h). The primary outcome was the incidence of sore throat at 24 h following surgery. The secondary outcomes were incidence and severity of sore throat and hoarseness. There were no significant differences in the incidence of sore throat at 24 h following surgery (57.8% vs. 46.5%; P = 0.290) or in the incidence and intensity of sore throat and hoarseness at 1, 6, and 24 h following surgery between the groups. A. vulgaris in glycerine did not significantly differ from dexamethasone for preventing sore throat and hoarseness owing to intubation.
Sections du résumé
BACKGROUND
BACKGROUND
Sore throat and hoarseness frequently occur following general anesthesia with tracheal intubation and are effectively reduced when dexamethasone is used prophylactically. Alchemilla vulgaris in glycerine (Neo Mucosal Activator®) suppresses inflammatory response, possibly relieving sore throat.
METHODS
METHODS
We enrolled 94 patients (age ≥ 18 years) scheduled for thoracic surgery using double-lumen tube intubation. Before intubation, 0.2 mg/kg of dexamethasone was administered intravenously and 2 ml of normal saline was sprayed into the oropharyngeal cavity (Group D; n = 45), or 0.04 ml/kg normal saline was administered intravenously and 1 g of Neo Mucosal Activator® mixed with 1 ml of normal saline was sprayed into the oropharyngeal cavity (Group N; n = 43), in a double blind and prospectively randomized manner. Postoperative sore throat and hoarseness were recorded using a numeral rating scale and a 4-point scale to detect a change in voice quality following tracheal extubation (at 1, 6, and 24 h). The primary outcome was the incidence of sore throat at 24 h following surgery. The secondary outcomes were incidence and severity of sore throat and hoarseness.
RESULTS
RESULTS
There were no significant differences in the incidence of sore throat at 24 h following surgery (57.8% vs. 46.5%; P = 0.290) or in the incidence and intensity of sore throat and hoarseness at 1, 6, and 24 h following surgery between the groups.
CONCLUSIONS
CONCLUSIONS
A. vulgaris in glycerine did not significantly differ from dexamethasone for preventing sore throat and hoarseness owing to intubation.
Identifiants
pubmed: 33866772
pii: apm.20082
doi: 10.17085/apm.20082
pmc: PMC8107251
doi:
Types de publication
Journal Article
Langues
eng
Pagination
163-170Subventions
Organisme : Dong-A University
Références
Int J Nurs Stud. 2016 Jan;53:260-9
pubmed: 26337854
Anesthesiology. 2011 Sep;115(3):575-88
pubmed: 21799397
Anesth Analg. 2010 Oct;111(4):887-91
pubmed: 20581162
Clin Drug Investig. 2006;26(10):567-73
pubmed: 17163290
Can J Anaesth. 2019 May;66(5):562-575
pubmed: 30617677
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):297-301
pubmed: 29249583
Can J Anaesth. 2015 Oct;62(10):1097-103
pubmed: 26149601
Pain Pract. 2015 Sep;15(7):604-9
pubmed: 24735082
Biomed Res Int. 2016;2016:4582439
pubmed: 28025646
Anaesthesia. 2016 Jun;71(6):706-17
pubmed: 27158989
J Cardiothorac Vasc Anesth. 2015 Aug;29(4):955-66
pubmed: 25753765
J Ethnopharmacol. 2019 Jun 28;238:111789
pubmed: 30904703
J Clin Anesth. 2015 Feb;27(1):45-50
pubmed: 25468585
Anesth Analg. 2008 Dec;107(6):1814-8
pubmed: 19020122
BMC Anesthesiol. 2017 Sep 12;17(1):127
pubmed: 28899338
J Oral Maxillofac Surg. 2018 Jan;76(1):60-66
pubmed: 28675812
Korean J Anesthesiol. 2016 Jun;69(3):255-61
pubmed: 27274371
Biomed Pharmacother. 2018 Oct;106:326-332
pubmed: 29966977
Expert Opin Drug Saf. 2019 Oct;18(10):883-891
pubmed: 31359807